Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Progesterone to Prevent Preterm Delivery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigating progesterone to prevent preterm delivery across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: The University of Hong Kong | Conditions: Preterm Birth | Phase 2, Phase 3 | Status: UNKNOWN